Evgenia I. Markelova

Moscow, MOW 129110, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis.

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis.

Journal: Life (Basel, Switzerland)

Published: December 12, 2022

Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment

Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.

Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.

Journal: Rheumatology international

Published: April 05, 2018

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.

Journal: Rheumatology international

Published: October 03, 2017

Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study

Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study

Journal: Terapevticheskii arkhiv

Published: June 21, 2017

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs

Journal: Terapevticheskii arkhiv

Published: May 31, 2016

Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases

Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases

Journal: Terapevticheskii arkhiv

Published: July 10, 2015

Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy

Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy

Journal: Terapevticheskii arkhiv

Published: July 10, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026